Aug 13, 2020
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
Aug 11, 2020
Romark Initiates New Phase 3 Clinical Trial Of NT-300 For The Treatment Of COVID-19
Jun 22, 2020
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
Jun 04, 2020
Novadoz Pharmaceuticals FDA Approvals of Oseltamivir and Dofetilide Continues the Company's Rise in the Generic Market
Jun 04, 2020
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum
Jun 02, 2020
World Markets for Interferons, 2030 (COVID-19 Adjusted) - Roche, Merck, BMS, Biogen, Bayer, Zydus Cadila, Novartis, Pfizer, Biosidus, and Nanogen are the Major Players
May 26, 2020
Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir
May 26, 2020
Glenmark to Commence New Phase 3 Clinical Trial on Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India
May 25, 2020
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum
May 19, 2020
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board
May 18, 2020
Enzychem Lifesciences Appoints Duke Medical Coronavirus Task Force Expert Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug
May 13, 2020
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
May 12, 2020
New Study: Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19
May 11, 2020
BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group
May 04, 2020
Collaborative Action for SARS-CoV2-Eradication (CARE) is Conducting Clinical Trials For Primary & Secondary Prophylaxis to Reduce COVID-19 Hospitalizations
May 01, 2020
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
Apr 30, 2020
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
Apr 27, 2020
Romark Initiates Phase 3 Clinical Trials Of NT-300 For COVID-19
Apr 23, 2020
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Apr 16, 2020
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola